Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Retinal optogenetic therapies: clinical criteria for candidacy.

Clinical genetics - 1 Aug 2013

Jacobson S G, Sumaroka A, Luo X, Cideciyan A V

Abstract excerpt

Severe blinding retinal degenerative diseases have been without treatments that could improve vision until recently. Gene therapy has been in clinical trials for certain inherited retinopathies in which photoreceptors are retained despite severe visual loss. Optogenetics is being discussed for retinal diseases in which there is severe visual loss and nearly complete photoreceptor cell death. As a retinal therapy,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkyl and Aryl Transferases
Share to Antigens, Neoplasm
Share to Eye Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leber Congenital Amaurosis

Share to Optogenetics

Share to Retina

Share to Retinitis Pigmentosa

Share to Tomography, Optical Coherence

Source

Identifiers

PMID: 23590195
DOI: 10.1111/cge.12165

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Retinal optogenetic therapies: clinical criteria for candidacy.PMID 23590195Read ↗

Inherited retinal diseases: Therapeutics, clinical trials and end points—A reviewSemantic proximity Read ↗

Inherited retinal degenerations: clinical phenotypes and emerging therapies.Semantic proximity Read ↗

Retinal blinding disorders and gene therapy--molecular and clinical aspects.Semantic proximity Read ↗

Retinitis pigmentosa: recent advances and future directions in diagnosis and managementSemantic proximity Read ↗

Retinitis Pigmentosa: Progress and Perspective.Semantic proximity Read ↗

Retinitis pigmentosa: understanding the clinical presentation, mechanisms and treatment optionsSemantic proximity Read ↗

Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical StrategiesSemantic proximity Read ↗

Emerging therapies for inherited retinal degeneration.Semantic proximity Read ↗

Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials.Semantic proximity Read ↗

Gene-agnostic approaches to treating inherited retinal degenerationsSemantic proximity Read ↗

Revisiting Retinal Degeneration Hallmarks: Insights from Molecular Markers and Therapy PerspectivesSemantic proximity Read ↗

Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.